ENZO BIOCHEM INC Quarterly Deferred Tax Assets, Net of Valuation Allowance in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Enzo Biochem Inc quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q2 2020 to Q2 2024.
  • Enzo Biochem Inc Deferred Tax Assets, Net of Valuation Allowance for the quarter ending July 31, 2024 was $29.7M, a 11.2% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $29.7M +$2.98M +11.2% Jul 31, 2024 10-K 2024-10-29
Q2 2023 $26.7M -$7.93M -22.9% Jul 31, 2023 10-K 2024-10-29
Q2 2022 $34.6M +$4.74M +15.9% Jul 31, 2022 10-K 2022-10-14
Q2 2021 $29.9M -$203K -0.68% Jul 31, 2021 10-K 2022-10-14
Q2 2020 $30.1M Jul 31, 2020 10-K 2021-10-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.